A multigene test could cost-effectively help extend life expectancy for women at risk of hereditary breast cancer—Reply to letter to the editor by Petelin et al.
Jul 1, 2018, 00:00 AM
10.1016/j.jval.2018.02.010
https://www.valueinhealthjournal.com/article/S1098-3015(18)30251-1/fulltext
Section Title :
CORRESPONDENCE
Section Order :
18
First Page :
893
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)30251-1&doi=10.1016/j.jval.2018.02.010